NEU 3.27% $20.51 neuren pharmaceuticals limited

It's good news but not surprising. Neuren have done a robust and...

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    It's good news but not surprising. Neuren have done a robust and clinical job in locking down their IP for a long time now. Dr T. is all over building value by making the technology exclusive and increase bargaining power.

    I wouldn't have expected anything less.

    SP is up could be due to the ann, but $2.50 was also the upward support line for the SP. Looks like support is respected and on the way up again.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.